ScreenerHero

XWELXWELL Inc. Common Stock

NAS · US · Consumer Defensive · Diagnostics & Research · xwell.com
1.040USD+9.47%Mkt Cap: 8.93M $P/E: —

XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally. It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment …

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$232.67BUSDP/E 33.9
DHR
Danaher Corporation
$153.85BUSDP/E 39.0
LONN
Lonza Group Ltd
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$47.86BUSD
A
Agilent Technologies, Inc.
$44.91BUSDP/E 31.9
IDXX
IDEXX Laboratories, Inc.
$43.93BUSDP/E 39.1
IQV
IQVIA Holdings Inc
$42.77BUSDP/E 32.3
WAT
Waters Corporation
$40.32BUSDP/E 103.5
ILMN
Illumina, Inc.
$33.13BUSDP/E 41.0
MTD
Mettler-Toledo International, Inc.
$27.96BUSDP/E 31.5
LH
Labcorp Holdings Inc.
$27.28BUSDP/E 27.8
DGX
Quest Diagnostics Incorporated
$26.97BUSDP/E 26.0
GH
Guardant Health, Inc.
$22.91BUSD
MEDP
Medpace Holdings, Inc.
$17.33BUSDP/E 36.4
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$14.09BUSD
RVTY
Revvity Inc. Common Stock
$13.92BUSDP/E 59.7
ICLR
ICON Public Limited Company
$13.29BUSDP/E 269.1
BIM
bioMerieux S.A.
$9.55BUSDP/E 19.1
TWST
Twist Bioscience Corp.
$9.13BUSD

Key Statistics

Company
Market Cap8.93M $
Enterprise Value13.61M $
Revenue (TTM)28.28M $
Gross Profit7.51M $
Net Income (TTM)-16.99M $
Revenue/Share4.121 USD
Last Price1.040 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees175
CountryUS
SectorConsumer Defensive
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.35
PEG—
EV/EBITDA-1.37
EV/Revenue0.48
P/S0.28
P/B18.98
EPS (TTM)-5.10
EPS (Forward)-2.63
52W Range
0.260040% of range2.200
52W High2.200 USD
52W Low0.2600 USD
Profitability
Gross Margin25.70%
Oper. Margin-26.10%
EBITDA Margin-35.15%
Profit Margin-58.17%
ROE77.10%
ROA-151.48%
Growth
Revenue Growth-7.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.71M $
CapEx (TTM)2.96M $
FCF Margin-32.23%
FCF Yield-102.05%
Net Debt-4.49M $
Net Debt/EBITDA0.45
Balance Sheet
Debt/Equity-0.57
Current Ratio2.27
Quick Ratio2.04
Book Value/Sh0.0490 USD
Cash/Share1.371 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 11, 2020
Splits
Last Split1:20
Split DateSep 28, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.8.59M
Float6.75M
Insiders17.80%
Institutions16.95%
Short Interest
Short Ratio1.2d
Short % Float3.11%
Short % Out.2.68%
Shares Short226.30K
Short (prev mo.)273.71K
Technical
SMA 501.053 (-1.2%)
SMA 2000.9671 (+7.5%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)39.71K
Avg Vol (10d)25.44K
Technical Indicators
RSI (14)50.9
MACD-0.0254
MACD Signal-0.0256
MACD Hist.+0.0002
BB Upper1.117 USD
BB Middle1.023 USD
BB Lower0.9291 USD
BB Width18.36%
ATR (14)0.0799 USD
Vol Ratio (20d)4.11x